Pfizer's official WeChat account announced on October 25th that the 2024 International Biomedical Industry Innovation Beijing Forum officially opened on the afternoon of October 24th. At the meeting, it was announced that Pfizer's Beijing R&D center will be located in BioPark, a pharmaceutical innovation park in Beijing Economic and Technological Development Zone (Beijing Yizhuang). Pfizer Beijing R&D Center will promote clinical trials in Beijing to synchronize with the global market, and carry out research and development of new products in the field of oncology and other areas.